1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells.

This publication has 30 references indexed in Scilit:

• 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells
  Biochemical and Biophysical Research Communications, 1981
• Hormonal Control of Skeletal Growth
  Annual Review of Physiology, 1981
• 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth
  Biochemical and Biophysical Research Communications, 1981
• 1,25-DIHYDROXYVITAMIN D₃AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTURE
  Endocrinology, 1981
• THE CONTROL OF CALCIUM AND PHOSPHORUS METABOLISM BY THE VITAMIN D ENDOCRINE SYSTEM*
  Annals of the New York Academy of Sciences, 1980
• Studies of the internalization of vitamin D3 metabolites by cultured osteogenic sarcoma cells and their application to a non-chromatographic cytoreceptor assay for 1,25-dihydroxyvitamin D3
  Biochemical and Biophysical Research Communications, 1980
• Recent Advances in the Understanding of the Metabolism and Functions of Vitamin D
  Published by Wolters Kluwer Health ,1980
• Glucocorticoids regulate the concentration of 1,25-dihydroxycholecalciferol receptors in bone
  Nature, 1979
• An in vitro production of bone specific alkaline phosphatase
  Experimental Cell Research, 1975
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
  Annals of the New York Academy of Sciences, 1949